Archives

Loading Events

The Epidemic Of Chronic Kidney Disease: Opportunities & Challenges For Hispanics/Latinos

The Epidemic Of Chronic Kidney Disease: Opportunities & Challenges For Hispanics/Latinos

Hispanics are the largest racial/ethnic minority group in the United States, and they experience a substantial burden of kidney disease. Although the prevalence of chronic kidney disease (CKD) is similar or slightly lower in Hispanics than non-Hispanic whites, the age- and sex-adjusted prevalence rate of end-stage renal disease is almost 50% higher in Hispanics compared with non-Hispanic whites.1 More than 25% of U.S. Hispanics report not having a regular health care provider, which is more than double the proportion for non-Hispanics whites.2 This disparity is likely related to socioeconomic factors including education, language, and lack of health insurance. Ultimately, Hispanics are less likely to receive pre-ESRD care than non-Hispanics. This webinar will discuss the epidemiology of chronic kidney disease in Hispanics, prevention, and management of risk factors for CKD in the Hispanic population and describe ESKD in Hispanics with mention of special vulnerable groups such as undocumented Hispanics.  

References:

  1. Desai et al. (2019). CKD and ESRD in US Hispanics. Am J Kidney Dis 73(1): 102–111.
  2. Pereira et al. (2021). Reducing the Burden of CKD among Latinx. CJASN 16(5):812-814.

Featuring

Sylvia Rosas

Sylvia Rosas, MD, MSCE

Nephrologist, Epidemiologist, Joslin Diabetes Center

Director of the Latino Kidney Clinic

Associate Professor of Medicine, Harvard Medical School

Nephrologist, Beth Israel Deaconess Medical Center

President Elect, National Kidney Foundation 2021-2022*

Dr Rosas is a nephrologist and epidemiologist at the Joslin Diabetes Center in Boston, MA. She is the Director of the Latino Kidney Clinic and an Associate Professor of Medicine at Harvard Medical School. She also is a nephrologist at the Beth Israel Deaconess Medical Center.
Dr Rosas completed medical school at University of Rosario in Bogota, Colombia and Internal Medicine training at Michael Reese Hospital/University of Illinois at Chicago. She obtained Clinical Nephrology training, a Master’s in Clinical Epidemiology as well as completed the Wharton Management Program from the University of Pennsylvania.
Dr Rosas’s primary research focus is on the epidemiology of metabolic and cardiovascular disease complications in patients with chronic kidney disease particularly diabetic kidney disease. She has also evaluated health disparities in individuals with CKD particularly in those of Hispanic/Latino background. She is the clinical center PI in the NIDDK-funded multicenter APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) that evaluates the role of the APOL1 gene in kidney transplant outcomes. She is also the PI for the Kidney Precision Medicine Program (KPMP) Chronic Kidney Disease recruitment site at Joslin Diabetes Center. KPMP aims to ethically obtain and evaluate human kidney biopsies in order to create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways, and targets for novel therapies. She is a member of the Editorial Board of the Clinical Journal of the American Society of Nephrology and the Advances of Chronic Kidney Disease Journal. Dr Rosas served as the Chair of the Minority Affairs Committee of the Organ Procurement and Transplant Network/United Network for Organ Sharing (UNOS). Dr Rosas has been the secretary for Women in Nephrology as well as Program Committee and Oversight Committee Chair for the NIDDK Network for Minority Health Research Investigators. She has received numerous awards including the National Kidney Foundation (NKF) of New England Physician of the Year in 2017, National Hispanic Medical Association Fellow of the Year Award and the 2021 ASN Midcareer Distinguished Leader Award. She is the President Elect of the National Kidney Foundation 2021-2022.

Claudia Lora

Claudia Lora, MD

Associate Professor, Department of Medicine’s Division of Nephrology, Assistant Dean of Graduate Medical Education

UI Health*

Dr Lora is an Associate Professor in the Department of Medicine’s Division of Nephrology and currently serves as Assistant Dean of Graduate Medical Education. After graduating from the University of Miami Honors Program with a major in English Literature, she enrolled at the University of Illinois College of Medicine, where she quickly fell in love with the city of Chicago and the patient population of UIHealth. Therefore, after completing the MD degree, she remained at UIHealth for residency in internal medicine and fellowship in nephrology. She also obtained a master’s in science in Clinical and Translational Research from UIC’s School of Public Health. After fellowship, Dr Lora received a career development award from the National Institute of Diabetes and Digestive and Kidney Diseases to examine health literacy in Hispanics/Latinos with chronic kidney disease. Since then, her research and clinical work have focused on addressing health disparities in kidney disease.

Lilia Cervantes

Lilia Cervantes, MD

Director of Immigrant Health, Associate Professor, Department of Medicine

University of Colorado Anschutz Medical Campus*

Dr Cervantes is the Director of Immigrant Health and an Associate Professor in the Department of Medicine at the University of Colorado Anschutz Medical Campus. Dr Cervantes received her undergraduate degree at CU Boulder and completed both her medical degree and internal medicine residency at the University of Colorado School of Medicine. Her background as a first-generation Latina inspired her deep commitment to becoming a physician as well as her community service, advocacy, and research focused on promoting social justice in medical education and kidney care. Dr Cervantes is recognized for spearheading an innovative change to a Medicaid payment rule in Colorado to give undocumented patients with kidney failure access to life-saving maintenance dialysis. The collaborative effort came after the passing of her patient and friend, Hilda, a young mother of two boys who was ineligible for routine dialysis due to her undocumented status. Her loss was life-changing for Dr Cervantes, and she coped with the loss through commitment and action. Through strategic documentation and dissection of the enormous human and economic costs of the status quo, and through grit and persistence, Dr Cervantes conducted research, developed a coalition of allies, and a policy remedy to save others like Hilda. The efforts have garnered national attention and partnerships, leading in turn, to efforts to enable routine dialysis for underserved patients in several other states. Following this defining experience, Dr Cervantes’ work has focused on eliminating structural racism in kidney health disparities. Dr Cervantes conducted mixed-methods studies to understand the social challenges and perspectives of Latinx with kidney failure and in partnership with a community advisory panel, translated her findings to create a peer navigator intervention. In addition to this work, Dr Cervantes has an RWJF Clinical Scholars grant focused on reducing the prevalence of kidney disease and its progression to kidney failure among Latinx with diabetes. During the COVID-19 pandemic, Dr Cervantes worked with the state Medicaid agency to expand outpatient COVID-19 care for undocumented immigrants, launched a government-funded community-based intervention to reduce COVID-19 infections for Latinx, and conducted a retrospective analysis and qualitative studies that assessed Latinx COVID-19 disparities. Dr Cervantes has received over 15 awards for her service to her community, is a member of nine civic and community activity boards and has been invited to speak at over 60 events, including an interview with NPR and CNN for her research.

Lisa Voigt

Lisa Voigt, PharmD, BCPS, BCCCP, FASHP

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Lisa Voigt is a PharmD who works as a Clinical & Scientific Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.

*Drs Rosas, Lora, and Cervantes are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Voigt is an employee of OPDC.

If you would like to register for the 6:00 pm to 7:00 pm EDT broadcast, please click below:

Registration

Please Log In Or Join to Register for this Event.

Related Resources